Skip to content

Clinical trials

Recruiting Immunoblastic Lymphadenopathy trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Immunoblastic Lymphadenopathy Status: Recruiting Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20092
20171
20211
20232
20242
20251
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting11

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
UNC Lineberger Comprehensive Cancer Center2
Alliance for Clinical Trials in Oncology1
Arvinas Inc.1
Corvus Pharmaceuticals, Inc.1
Fudan University1
Mayo Clinic1
Memorial Sloan Kettering Cancer Center1
National Cancer Institute (NCI)1
SciTech Development, Inc.1
SecuraBio1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Immunoblastic Lymphadenopathy11
Lymphoma, Large-Cell, Anaplastic6
Lymphoma, T-Cell6
Lymphoma, T-Cell, Cutaneous5
Lymphoma, T-Cell, Peripheral5
Mycosis Fungoides5
Lymphoma4
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma4
Sezary Syndrome4
Leukemia, Large Granular Lymphocytic3

Trials

Showing 51 to 11 of 11. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.